SCHEMBL7679353

SCHEMBL7679353

COc1cccc(NC(=O)c2c[nH]c3c(c2=O)CCC3)c1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 5/20 0.66
RAB9A P51151 9/20 0.56
NPC1 O15118 8/20 0.56
SMN1; SMN2 Q16637 5/20 0.56
KMT2A Q03164 3/20 0.56
CASP3 P42574 2/20 0.56
SENP7 Q9BQF6 2/20 0.56
MEN1 O00255 1/20 0.56
SENP8 Q96LD8 1/20 0.56
SENP6 Q9GZR1 1/20 0.56
MAPT P10636 2/20 0.55
POLB P06746 1/20 0.49
RXFP1 Q9HBX9 1/20 0.49
GRM5 P41594 1/20 0.48
KDM4E B2RXH2 1/20 0.48
GAA P10253 1/20 0.48
NLRP3 Q96P20 1/20 0.48
ALDH1A1 P00352 1/20 0.48
PKM P14618 1/20 0.48
LMNA P02545 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7446245 0.98 TP53 (0.68) TP53RAB9ANPC1SMN1; SMN2KMT2A
SCHEMBL7680828 0.86 MAPT (0.61) TP53RAB9ANPC1SMN1; SMN2KMT2A
SCHEMBL7399600 0.85 TP53 (0.55) TP53RAB9ANPC1SMN1; SMN2KMT2A
SCHEMBL7446323 0.84 MAPT (0.64) TP53RAB9ANPC1SMN1; SMN2CASP3
SCHEMBL7676003 0.83 MAPT (0.62) TP53RAB9ANPC1SMN1; SMN2KMT2A
SCHEMBL7682505 0.83 MAOB (0.46) TP53RAB9ANPC1SMN1; SMN2KMT2A
SCHEMBL7366681 0.83 TP53 (0.57) TP53RAB9ANPC1SMN1; SMN2KMT2A
SCHEMBL7679755 0.82 CFTR (0.56) TP53SMN1; SMN2KMT2AMEN1MAPT
SCHEMBL6163180 0.82 NPC1 (0.58) RAB9ANPC1MAPTPOLBKDM4E
SCHEMBL7449715 0.81 TP53 (0.48) TP53RAB9ANPC1KMT2ACASP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6448259-B1 CYCLOALKYL-4-OXONICOTINIC CARBOXAMIDES; AGONISTS, ANTAGONISTS OR INVERSE AGONISTS FOR GAMMA AMINOBUTYRIC ACID BINDING SITE, THE BENZODIAZEPINE RECEPTOR; ANXIETY, SLEEP AND SEIZURE DISORDERS SEDATIVE, ANXIOLYTIC AND ANTICONVULSANT ACTIVITY NEUROGEN CORPORATION 2002-09-10 US claimed
US-6448259-B1 CYCLOALKYL-4-OXONICOTINIC CARBOXAMIDES; AGONISTS, ANTAGONISTS OR INVERSE AGONISTS FOR GAMMA AMINOBUTYRIC ACID BINDING SITE, THE BENZODIAZEPINE RECEPTOR; ANXIETY, SLEEP AND SEIZURE DISORDERS SEDATIVE, ANXIOLYTIC AND ANTICONVULSANT ACTIVITY NEUROGEN CORPORATION 2002-09-10 US disclosed
US-6194427-B1 BRAIN DISORDERS; PSYCHOLOGICAL DISORDERS; SLEEP DISORDERS; ANTICONVULSANTS NEUROGEN CORPORATION 2001-02-27 US disclosed